Dr. Adel Laoui is an International Senior Executive that has more than 20+ years’ experience in R&D interfacing between Life sciences and Technologies across US, EMEA and APAC. Adel holds a PhD in Chemical Physics and Informatics. His expertise resides in Pharmaceuticals, Healthcare Technology and Artificial Intelligence.
Dr. Laoui has an MBA degree on advanced finance, marketing and business strategy that complete his profile combining science, technology, and business skills. He applies the learning to developing novel business models for complex integrated healthcare solutions that bundle medical with technology and service. He has dedicated the last 10 years on innovation of Medical Technologies to explore a more entrepreneurial path by joining the West Coast eco-system and expand his horizon from corporate to startups. Adel spent 5 years leading MedTech companies, business divisions and groups in the areas of machine learning analytics, digital genomics, and mobile integrated healthcare. Adel contributed to the sale of a software company, acquired by Dassault Systemes for $750M a 7X return. He is now leading the charge in the field of Artificial Intelligence as CEO & Founder of a new startup NeuTigers, a spin out from Princeton University.